Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A tumor cell is an abnormal cell that has undergone genetic and epigenetic changes, resulting in uncontrolled growth and division. These cells can form masses known as tumors (neoplasms), which may be benign (non-cancerous) or malignant (cancerous). Malignant tumor cells are the hallmark of cancer and possess unique characteristics that distinguish them from normal, healthy cells. They exhibit uncontrolled proliferation, resistance to cell death, and the ability to invade and metastasize.
Various mechanisms targeting uncontrolled cell division pathways, angiogenesis factors, and immune evasion mechanisms.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell.